AstraZeneca (AZN)
(Delayed Data from NSDQ)
$79.53 USD
-0.54 (-0.67%)
Updated Jun 13, 2024 04:00 PM ET
Pre-Market: $79.32 -0.21 (-0.26%) 8:18 AM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
AstraZeneca PLC [AZN]
Reports for Purchase
Showing records 61 - 80 ( 258 total )
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended December 10
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Durvalumab COAST Update Makes a Splash at ESMO
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 2
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Key Takeaways From COVID-19 Vaccines and Antivirals Panels at Life Sciences Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 26
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D